|
Partnering with pharmaceutical and biotechnology companies
is a key component of our business strategy.
Mercator MedSystems has several corporate partnerships with companies who are seeking to improve therapeutic effectiveness, safety and yield by direct delivery to the desired locus of action. We are looking to develop additional relationships to expand the application of the company's MicroSyringe platform for site-specific drug delivery. Mercator MedSystems’ technology enables catheter-guided, non-sytemic delivery of therapeutic agents through the vasculature into surrounding tissue in a highly controllable and repeatable way.
We believe that new therapeutics and product line extensions will benefit from non-systemic, site-specific drug delivery. Mercator MedSystems is interested in collaborating with companies that possess proprietary therapeutics, including stem cells, growth factors, and novel therapeutic compounds.
If you are interested in exploring a corporate partnership with Mercator MedSystems or would like additional information, please contact:
Wendy Hitchcock
Chief Business Officer and Executive Vice President
Finance and Corporate Development
BusinessDevelopment@mercatormed.com
|
